Inspire Medical Systems, Inc. (INSP)
Automate Your Wheel Strategy on INSP
With Tiblio's Option Bot, you can configure your own wheel strategy including INSP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol INSP
- Rev/Share 29.1901
- Book/Share 22.9713
- PB 5.4999
- Debt/Equity 0.0488
- CurrentRatio 6.1396
- ROIC 0.0526
- MktCap 3738574570.0
- FreeCF/Share 2.8809
- PFCF 43.9796
- PE 70.1778
- Debt/Assets 0.0412
- DivYield 0
- ROE 0.0787
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | INSP | Morgan Stanley | Overweight | Equal Weight | -- | $130 | Dec. 2, 2025 |
| Upgrade | INSP | Truist | Hold | Buy | -- | $165 | Nov. 26, 2025 |
| Upgrade | INSP | Wolfe Research | Peer Perform | Outperform | -- | $180 | Nov. 25, 2025 |
| Upgrade | INSP | Stifel | Hold | Buy | -- | -- | Nov. 24, 2025 |
| Upgrade | INSP | Wells Fargo | Equal Weight | Overweight | -- | $90 | Nov. 4, 2025 |
| Downgrade | INSP | Jefferies | Buy | Hold | -- | $85 | Oct. 24, 2025 |
| Downgrade | INSP | UBS | Buy | Neutral | -- | $89 | Sept. 22, 2025 |
| Initiation | INSP | Evercore ISI | -- | Outperform | -- | $150 | Sept. 2, 2025 |
| Downgrade | INSP | JP Morgan | Overweight | Neutral | -- | $110 | Aug. 5, 2025 |
| Downgrade | INSP | Truist | Buy | Hold | -- | $125 | Aug. 5, 2025 |
News
Inspire Medical Systems, Inc. (INSP) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Published: December 02, 2025 by: Seeking Alpha
Sentiment: Neutral
Inspire Medical Systems, Inc. (INSP) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Read More
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: December 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.
Read More
INSP SHAREHOLDERS: Inspire Medical Systems, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by January 5
Published: December 01, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - December 1, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
Read More
INSP INVESTOR ALERT: Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
Published: December 01, 2025 by: PRNewsWire
Sentiment: Neutral
INSP Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Dec. 1, 2025 /PRNewswire/ -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea. Hagens Berman is investigating the allegations.
Read More
INSP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: December 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Inspire securities between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”).
Read More
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: December 01, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Dec. 1, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP). IF YOU SUFFERED A LOSS ON YOUR INSPIRE INVESTMENTS, CLICK HERE BEFORE JANUARY 5, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
Read More
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Published: November 28, 2025 by: Newsfile Corp
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 28, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical …
Read More
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: November 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.
Read More
Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
Published: November 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea. Hagens Berman is investigating the allegations.
Read More
INSP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: November 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) and certain of its officers.
Read More
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Published: November 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
Inspire Medical (INSP) Faces Securities Class Action Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
Published: November 26, 2025 by: PRNewsWire
Sentiment: Neutral
SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea. Hagens Berman is investigating the allegations.
Read More
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: November 25, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Nov. 25, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP) have opportunity to lead the securities fraud class action lawsuit.
Read More
Inspire Medical: Buy Or Sell INSP Stock After Its 30% Rally?
Published: November 25, 2025 by: Forbes
Sentiment: Neutral
Inspire Medical Systems' stock recently saw a significant surge, reacting to news that appears to be important. But does the increase from yesterday indicate that this is a good time to buy, or are we merely trying to catch a falling knife?
Read More
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: November 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.
Read More
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.
Read More
Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea.
Read More
INSP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) and certain of its officers.
Read More
Inspire Medical Stock Is Down 41% This Year. Why It's Surging Today.
Published: November 24, 2025 by: Barrons
Sentiment: Positive
The maker of an implant to treat sleep apnea receives an upgrade to Buy from Hold at Stifel.
Read More
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: November 21, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , Nov. 21, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Read More
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Published: November 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.
Read More
Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
Published: November 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical “next generation” sleep apnea device, the Inspire V. The litigation zeroes in on the disparity between the company's confident assurances and the subsequent disastrous rollout that led to a dramatic stock crash.
Read More
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: November 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.
Read More
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Published: November 21, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 21, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. …
Read More
INSP INVESTORS: BFA Law Reminds Inspire Medical Systems, Inc. Investors with Losses to Contact the Firm Before the Imminent January 5 Securities Class Action Deadline
Published: November 20, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
Read More
Deadline Alert: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: November 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).
Read More
INSP INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Published: November 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. …
Read More
Attention Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office is Investigating Claims on Your Behalf
Published: November 20, 2025 by: Newsfile Corp
Sentiment: Neutral
Philadelphia, Pennsylvania--(Newsfile Corp. - November 20, 2025) - Grabar Law Office is investigating claims on behalf of Inspire Medical Systems, Inc. (NYSE: INSP) shareholders. The investigation concerns whether certain officers of Inspire Medical have breached their fiduciary duties owed to the company.
Read More
Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
Published: November 20, 2025 by: Newsfile Corp
Sentiment: Neutral
INSP Investors with Losses Encouraged to Contact Hagens Berman San Francisco, California--(Newsfile Corp. - November 20, 2025) - Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical "next generation" sleep apnea device, the Inspire V. The litigation zeroes in on the disparity between the company's confident assurances and the subsequent disastrous rollout that led to a dramatic stock crash.
Read More
INSP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: November 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) and certain of its officers.
Read More
About Inspire Medical Systems, Inc. (INSP)
- IPO Date 2018-05-03
- Website https://www.inspiresleep.com
- Industry Medical - Devices
- CEO Timothy P. Herbert
- Employees 1246